| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.635 | 0.006 | 0.676 | Hypoglycemic | 0.676 0.005 DBMET00884 | DBMET00884 | |
| 0.452 | 0.01 | 0.474 | Diuretic | 0.474 0.009 DBMET00884 | DBMET00884 | |
| 0.426 | 0.005 | 0.443 | Insulin secretagoues | 0.443 0.005 DBMET00884 | DBMET00884 | |
| 0.477 | 0.098 | 0.526 | Antiinflammatory | 0.526 0.077 DBMET00884 | DBMET00884 | |
| 0.382 | 0.031 | 0.418 | Platelet antagonist | 0.418 0.024 DBMET00884 | DBMET00884 | |
| 0.408 | 0.097 | 0.408 | Beta lactamase inhibitor | |||
| 0.292 | 0.007 | 0.292 | Neuropeptide Y antagonist | 0.148 0.022 DBMET00884 | ||
| 0.281 | 0.005 | 0.281 | Carbonic anhydrase XII inhibitor | 0.075 0.027 DBMET00884 | ||
| 0.264 | 0.005 | 0.264 | Carbonic anhydrase IX inhibitor | 0.076 0.029 DBMET00884 | ||
| 0.256 | 0.005 | 0.256 | Carbonic anhydrase inhibitor | 0.128 0.02 DBMET00884 | ||
| 0.341 | 0.091 | 0.341 | Calpain 2 inhibitor | 0.239 0.157 DBMET00884 | ||
| 0.28 | 0.048 | 0.28 | Gastrin inhibitor | |||
| 0.227 | 0.004 | 0.227 | Potassium channel (ATP-sensitive) blocker | 0.157 0.005 DBMET00884 | ||
| 0.225 | 0.002 | 0.225 | Potassium channel Kv1.1 blocker | 0.064 0.008 DBMET00884 | ||
| 0.343 | 0.127 | 0.581 | Cyclophilin D inhibitor | 0.581 0.031 DBMET00884 | DBMET00884 | |
| 0.301 | 0.087 | 0.398 | Antithrombotic | 0.398 0.05 DBMET00884 | DBMET00884 | |
| 0.266 | 0.058 | 0.266 | 5 Hydroxytryptamine 1E antagonist | 0.179 0.155 DBMET00884 | ||
| 0.268 | 0.065 | 0.268 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.32 | 0.118 | 0.32 | 15-Lipoxygenase inhibitor | |||
| 0.204 | 0.007 | 0.204 | Carbonic anhydrase V inhibitor | 0.144 0.016 DBMET00884 | ||
| 0.256 | 0.06 | 0.256 | Calpain inhibitor | 0.185 0.129 DBMET00884 | ||
| 0.191 | 0.005 | 0.191 | Carbonic anhydrase VA inhibitor | 0.129 0.015 DBMET00884 | ||
| 0.199 | 0.014 | 0.199 | Carbonic anhydrase XIII inhibitor | 0.146 0.023 DBMET00884 | ||
| 0.185 | 0.005 | 0.185 | CC chemokine 3 receptor antagonist | 0.059 0.02 DBMET00884 | ||
| 0.185 | 0.007 | 0.185 | Carbonic anhydrase I inhibitor | 0.086 0.023 DBMET00884 | ||
| 0.194 | 0.019 | 0.194 | Chemokine receptor antagonist | 0.13 0.042 DBMET00884 | ||
| 0.17 | 0.003 | 0.17 | Bombesin 3 receptor antagonist | 0.161 0.003 DBMET00884 | ||
| 0.171 | 0.008 | 0.171 | Carbonic anhydrase II inhibitor | 0.073 0.028 DBMET00884 | ||
| 0.232 | 0.075 | 0.232 | Neuropeptide Y2 antagonist | 0.182 0.155 DBMET00884 | ||
| 0.242 | 0.088 | 0.279 | Cardiotonic | 0.279 0.066 DBMET00884 | DBMET00884 | |
| 0.155 | 0.011 | 0.155 | Epoxide hydrolase inhibitor | 0.074 0.048 DBMET00884 | ||
| 0.145 | 0.009 | 0.145 | Neuropeptide Y5 antagonist | 0.095 0.017 DBMET00884 | ||
| 0.139 | 0.007 | 0.139 | Carbonic anhydrase VII inhibitor | 0.058 0.02 DBMET00884 | ||
| 0.186 | 0.055 | 0.186 | Phospholipase C inhibitor | 0.148 0.111 DBMET00884 | ||
| 0.201 | 0.07 | 0.201 | Platelet adhesion inhibitor | 0.183 0.08 DBMET00884 | ||
| 0.133 | 0.005 | 0.156 | Thromboxane antagonist | 0.156 0.004 DBMET00884 | DBMET00884 | |
| 0.146 | 0.02 | 0.146 | Metalloproteinase-2 inhibitor | 0.123 0.028 DBMET00884 | ||
| 0.127 | 0.005 | 0.153 | Thromboxane A2 antagonist | 0.153 0.004 DBMET00884 | DBMET00884 | |
| 0.135 | 0.014 | 0.135 | Neutrophil collagenase inhibitor | 0.081 0.031 DBMET00884 | ||
| 0.122 | 0.004 | 0.122 | Carbonic anhydrase I stimulant | 0.112 0.004 DBMET00884 | ||
| 0.276 | 0.16 | 0.276 | MAP kinase kinase 6 inhibitor | |||
| 0.119 | 0.004 | 0.119 | Potassium channel (Inward rectifier) activator | 0.086 0.006 DBMET00884 | ||
| 0.222 | 0.109 | 0.222 | Transcription factor STAT3 inhibitor | |||
| 0.116 | 0.004 | 0.116 | Carbonic anhydrase II stimulant | 0.107 0.004 DBMET00884 | ||
| 0.115 | 0.004 | 0.115 | Potassium channel (ATP-sensitive) activator | 0.081 0.007 DBMET00884 | ||
| 0.279 | 0.171 | 0.279 | Alpha-glucosidase inhibitor | |||
| 0.226 | 0.122 | 0.226 | Insulysin inhibitor | |||
| 0.185 | 0.082 | 0.185 | Focal adhesion kinase 2 inhibitor | 0.168 0.103 DBMET00884 | ||
| 0.112 | 0.009 | 0.119 | Glycine transporter inhibitor | 0.119 0.009 DBMET00884 | DBMET00884 | |
| 0.125 | 0.024 | 0.125 | CC chemokine receptor antagonist | 0.088 0.044 DBMET00884 | ||
| 0.108 | 0.009 | 0.108 | Carbonic anhydrase XIV inhibitor | 0.105 0.009 DBMET00884 | ||
| 0.125 | 0.027 | 0.141 | Carbonic anhydrase VI inhibitor | 0.141 0.023 DBMET00884 | DBMET00884 | |
| 0.121 | 0.024 | 0.121 | Metalloproteinase-9 inhibitor | 0.108 0.029 DBMET00884 | ||
| 0.138 | 0.044 | 0.138 | CC chemokine 6 receptor antagonist | 0.136 0.051 DBMET00884 | ||
| 0.11 | 0.016 | 0.214 | Carbonic anhydrase stimulant | 0.214 0.007 DBMET00884 | DBMET00884 | |
| 0.28 | 0.188 | 0.28 | 5 Hydroxytryptamine release inhibitor | |||
| 0.098 | 0.007 | 0.169 | Potassium channel (Inward rectifier) blocker | 0.169 0.004 DBMET00884 | DBMET00884 | |
| 0.101 | 0.016 | 0.101 | Vanilloid 4 agonist | 0.095 0.021 DBMET00884 | ||
| 0.102 | 0.017 | 0.102 | Bcl2 antagonist | 0.085 0.028 DBMET00884 | ||
| 0.222 | 0.137 | 0.222 | Thyroid hormone beta antagonist | |||
| 0.186 | 0.102 | 0.217 | Potassium channel blocker | 0.217 0.082 DBMET00884 | DBMET00884 | |
| 0.159 | 0.078 | 0.159 | Cyclin-dependent kinase 3 inhibitor | 0.148 0.1 DBMET00884 | ||
| 0.09 | 0.009 | 0.09 | Aldosterone antagonist | |||
| 0.083 | 0.007 | 0.083 | Collagenase inhibitor | 0.066 0.011 DBMET00884 | ||
| 0.102 | 0.026 | 0.102 | Matrix metalloproteinase inhibitor | 0.083 0.035 DBMET00884 | ||
| 0.097 | 0.026 | 0.097 | CXC chemokine receptor antagonist | |||
| 0.142 | 0.078 | 0.142 | Neuropeptide Y1 antagonist | |||
| 0.082 | 0.02 | 0.082 | Acetyl-CoA transferase inhibitor | 0.048 0.045 DBMET00884 | ||
| 0.073 | 0.011 | 0.073 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.12 | 0.06 | 0.12 | Caspase 3 inhibitor | |||
| 0.098 | 0.039 | 0.098 | Glutathione S-transferase inhibitor | 0.085 0.054 DBMET00884 | ||
| 0.082 | 0.023 | 0.082 | Collagenase 3 inhibitor | |||
| 0.103 | 0.045 | 0.103 | Potassium channel activator | 0.08 0.075 DBMET00884 | ||
| 0.21 | 0.153 | 0.21 | Thyroid hormone antagonist | |||
| 0.175 | 0.119 | 0.175 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.078 | 0.022 | 0.078 | Matrix metalloproteinase 1 inhibitor | 0.052 0.037 DBMET00884 | ||
| 0.074 | 0.019 | 0.074 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.13 | 0.076 | 0.13 | Alkaline phosphatase inhibitor | |||
| 0.068 | 0.016 | 0.083 | Purinergic P2Y antagonist | 0.083 0.012 DBMET00884 | DBMET00884 | |
| 0.141 | 0.09 | 0.141 | Hexokinase inhibitor | |||
| 0.104 | 0.053 | 0.104 | Electrolyte absorption antagonist | 0.098 0.06 DBMET00884 | ||
| 0.086 | 0.036 | 0.086 | Thrombin inhibitor | 0.079 0.043 DBMET00884 | ||
| 0.122 | 0.073 | 0.122 | Cathepsin H inhibitor | |||
| 0.193 | 0.144 | 0.193 | MAP kinase kinase 3 inhibitor | 0.186 0.168 DBMET00884 | ||
| 0.155 | 0.108 | 0.155 | Non-steroidal antiinflammatory agent | 0.142 0.126 DBMET00884 | ||
| 0.069 | 0.022 | 0.069 | Bcl-xL inhibitor | 0.062 0.036 DBMET00884 | ||
| 0.056 | 0.01 | 0.056 | Aggrecanase 1 inhibitor | 0.047 0.017 DBMET00884 | ||
| 0.064 | 0.018 | 0.064 | HCV NS3/NS4A protease inhibitor | 0.052 0.03 DBMET00884 | ||
| 0.049 | 0.006 | 0.049 | Epoxide hydrolase 2 inhibitor | 0.039 0.009 DBMET00884 | ||
| 0.073 | 0.031 | 0.073 | Trypsin inhibitor | 0.068 0.035 DBMET00884 | ||
| 0.068 | 0.028 | 0.117 | Beta 1 adrenoreceptor antagonist | 0.117 0.007 DBMET00884 | DBMET00884 | |
| 0.048 | 0.01 | 0.056 | Angiotensin AT2 receptor antagonist | 0.056 0.009 DBMET00884 | DBMET00884 | |
| 0.189 | 0.152 | 0.189 | Lipoxygenase inhibitor | |||
| 0.081 | 0.045 | 0.081 | GABA aminotransferase inhibitor | |||
| 0.067 | 0.031 | 0.067 | Potassium channel Kv1.5 blocker | 0.056 0.041 DBMET00884 | ||
| 0.056 | 0.021 | 0.056 | Carbonic anhydrase IV inhibitor | |||
| 0.204 | 0.169 | 0.204 | Thioredoxin glutathione reductase inhibitor | |||
| 0.039 | 0.004 | 0.039 | Carbonic anhydrase IV stimulant | 0.034 0.004 DBMET00884 | ||
| 0.055 | 0.021 | 0.055 | Macrophage elastase inhibitor | 0.041 0.032 DBMET00884 | ||
| 0.049 | 0.015 | 0.049 | Phenylethanolamine N methyltransferase inhibitor | 0.042 0.025 DBMET00884 | ||
| 0.075 | 0.043 | 0.075 | Prostaglandin-E synthase inhibitor | |||
| 0.048 | 0.016 | 0.058 | Glycine transporter 1 inhibitor | 0.058 0.013 DBMET00884 | DBMET00884 | |
| 0.035 | 0.005 | 0.035 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.038 | 0.009 | 0.038 | CXC chemokine 2 receptor antagonist | 0.027 0.018 DBMET00884 | ||
| 0.067 | 0.038 | 0.067 | Cannabinoid CB1 receptor antagonist | |||
| 0.044 | 0.016 | 0.044 | Glucose-6-phosphate dehydrogenase inhibitor | 0.036 0.029 DBMET00884 | ||
| 0.191 | 0.162 | 0.191 | 12-Lipoxygenase inhibitor | |||
| 0.053 | 0.026 | 0.054 | Potassium channel Kv1.3 blocker | 0.054 0.026 DBMET00884 | DBMET00884 | |
| 0.045 | 0.019 | 0.045 | Farnesoid X receptor agonist | 0.042 0.021 DBMET00884 | ||
| 0.057 | 0.035 | 0.084 | Glucosylceramidase inhibitor | 0.084 0.013 DBMET00884 | DBMET00884 | |
| 0.112 | 0.093 | 0.112 | NADPH oxidase inhibitor | |||
| 0.04 | 0.021 | 0.04 | Integrin alpha2 antagonist | 0.039 0.021 DBMET00884 | ||
| 0.028 | 0.009 | 0.028 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.048 | 0.031 | 0.048 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.038 | 0.02 | 0.038 | RNA-directed RNA polymerase inhibitor | |||
| 0.043 | 0.026 | 0.043 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.176 | 0.159 | 0.211 | DNA synthesis inhibitor | 0.211 0.107 DBMET00884 | DBMET00884 | |
| 0.051 | 0.034 | 0.071 | Prostaglandin E2 antagonist | 0.071 0.023 DBMET00884 | DBMET00884 | |
| 0.061 | 0.045 | 0.061 | I kappa B kinase 2 inhibitor | |||
| 0.033 | 0.018 | 0.046 | Cyclophilin A inhibitor | 0.046 0.008 DBMET00884 | DBMET00884 | |
| 0.067 | 0.053 | 0.067 | Cannabinoid receptor antagonist | |||
| 0.042 | 0.031 | 0.042 | Leukocyte elastase inhibitor | |||
| 0.028 | 0.016 | 0.028 | Calcium-sensing receptor agonist | |||
| 0.052 | 0.042 | 0.063 | Thromboxane synthase inhibitor | 0.063 0.024 DBMET00884 | DBMET00884 | |
| 0.035 | 0.025 | 0.035 | AMPA receptor agonist | 0.034 0.028 DBMET00884 | ||
| 0.022 | 0.014 | 0.022 | Angiotensin AT1A receptor antagonist | 0.022 0.014 DBMET00884 | ||
| 0.021 | 0.014 | 0.021 | Factor XIII inhibitor | |||
| 0.016 | 0.009 | 0.016 | CC chemokine 10 receptor antagonist | 0.016 0.009 DBMET00884 | ||
| 0.03 | 0.023 | 0.03 | HCV NS5B polymerase inhibitor | |||
| 0.022 | 0.017 | 0.052 | Beta 1 adrenoreceptor agonist | 0.052 0.004 DBMET00884 | DBMET00884 | |
| 0.033 | 0.027 | 0.033 | HCV polyprotein inhibitor | |||
| 0.023 | 0.017 | 0.023 | CC chemokine 1 receptor antagonist | |||
| 0.104 | 0.099 | 0.104 | Cyclooxygenase 2 inhibitor | |||
| 0.083 | 0.079 | 0.098 | Aminopeptidase B inhibitor | 0.098 0.066 DBMET00884 | DBMET00884 | |
| 0.026 | 0.022 | 0.026 | Bradykinin B1 receptor antagonist | |||
| 0.027 | 0.024 | 0.031 | Prostaglandin EP3 antagonist | 0.031 0.02 DBMET00884 | DBMET00884 | |
| 0.052 | 0.049 | 0.069 | Sphingosine 1-phosphate receptor 1 antagonist | 0.069 0.019 DBMET00884 | DBMET00884 | |
| 0.022 | 0.023 | 0.053 | Prostaglandin EP4 antagonist | 0.053 0.008 DBMET00884 | DBMET00884 | |
| 0.07 | 0.073 | 0.08 | Sphingosine 1-phosphate receptor antagonist | 0.08 0.045 DBMET00884 | DBMET00884 | |
| 0.066 | 0.071 | 0.139 | Somatostatin 1 agonist | 0.139 0.016 DBMET00884 | DBMET00884 | |
| 0.057 | 0.061 | 0.107 | Beta adrenoreceptor antagonist | 0.107 0.014 DBMET00884 | DBMET00884 | |
| 0.057 | 0.065 | 0.103 | Beta 3 adrenoreceptor antagonist | 0.103 0.014 DBMET00884 | DBMET00884 | |
| 0.041 | 0.05 | 0.115 | Beta 2 adrenoreceptor antagonist | 0.115 0.006 DBMET00884 | DBMET00884 | |
| 0.057 | 0.065 | 0.079 | Beta 2 adrenoreceptor agonist | 0.079 0.009 DBMET00884 | DBMET00884 | |
| 0.041 | 0.05 | 0.059 | Prostaglandin antagonist | 0.059 0.033 DBMET00884 | DBMET00884 | |
| 0.036 | 0.045 | 0.045 | Angiotensin AT1 receptor antagonist | 0.045 0.025 DBMET00884 | DBMET00884 | |
| 0.051 | 0.066 | 0.073 | Prostaglandin F2 alpha antagonist | 0.073 0.029 DBMET00884 | DBMET00884 | |
| 0.083 | 0.099 | 0.095 | Carbonic anhydrase XV inhibitor | 0.095 0.075 DBMET00884 | DBMET00884 | |
| 0.042 | 0.061 | 0.053 | Alpha 1b adrenoreceptor agonist | 0.053 0.029 DBMET00884 | DBMET00884 | |
| 0.118 | 0.137 | 0.151 | Pregnane X receptor agonist | 0.151 0.051 DBMET00884 | DBMET00884 | |
| 0.04 | 0.059 | 0.065 | Beta adrenoreceptor agonist | 0.065 0.006 DBMET00884 | DBMET00884 | |
| 0.026 | 0.046 | 0.035 | Angiotensin II receptor antagonist | 0.035 0.022 DBMET00884 | DBMET00884 | |
| 0.089 | 0.112 | 0.102 | Nav1.3 sodium channel blocker | 0.102 0.095 DBMET00884 | DBMET00884 | |
| 0.005 | 0.029 | 0.033 | Beta 3 adrenoreceptor agonist | 0.033 0.004 DBMET00884 | DBMET00884 | |
| 0.105 | 0.134 | 0.125 | Anticoagulant | 0.125 0.106 DBMET00884 | DBMET00884 | |
| 0.13 | 0.159 | 0.152 | Platelet aggregation inhibitor | 0.152 0.127 DBMET00884 | DBMET00884 | |
| 0.072 | 0.112 | 0.091 | Carbonic anhydrase III inhibitor | 0.091 0.073 DBMET00884 | DBMET00884 | |
| 0.057 | 0.099 | 0.193 | Adrenaline agonist | 0.193 0.008 DBMET00884 | DBMET00884 | |
| 0.082 | 0.133 | 0.121 | Alpha-N-acetylglucosaminidase inhibitor | 0.121 0.077 DBMET00884 | DBMET00884 | |
| 0.076 | 0.129 | 0.107 | Amylase inhibitor | 0.107 0.091 DBMET00884 | DBMET00884 | |
| 0.106 | 0.161 | 0.157 | Adenylate cyclase stimulant | 0.157 0.052 DBMET00884 | DBMET00884 | |
| 0.177 | 0.234 | 0.39 | Toll-Like receptor 7 agonist | 0.39 0.064 DBMET00884 | DBMET00884 | |
| 0.168 | 0.245 | 0.383 | Toll-Like receptor agonist | 0.383 0.067 DBMET00884 | DBMET00884 | |
| 0.014 | 0.122 | 0.029 | Potassium channel (Inward rectifier) 1 blocker | 0.029 0.026 DBMET00884 | DBMET00884 | |
| 0.148 | 0.272 | 0.242 | Sodium/bile acid cotransporter inhibitor | 0.242 0.137 DBMET00884 | DBMET00884 | |
| 0.125 | 0.282 | 0.281 | Peptidyltransferase inhibitor | 0.281 0.033 DBMET00884 | DBMET00884 | |
| 0.013 | 0.177 | 0.054 | Prostaglandin EP2 antagonist | 0.054 0.047 DBMET00884 | DBMET00884 | |
| 0.04 | 0.216 | 0.216 | Bronchodilator | 0.216 0.016 DBMET00884 | DBMET00884 | |
| 0.138 | 0.335 | 0.268 | Analgesic | 0.268 0.167 DBMET00884 | DBMET00884 | |
| 0.07 | 0.283 | 0.2 | Hypolipemic | 0.2 0.094 DBMET00884 | DBMET00884 | |
| 0.073 | 0.445 | 0.295 | Antiobesity | 0.295 0.119 DBMET00884 | DBMET00884 | |
| 0.028 | 0.472 | 0.107 | Nav1.4 sodium channel blocker | 0.107 0.066 DBMET00884 | DBMET00884 | |
| 0.105 | 0.586 | 0.491 | Calcium channel L-type activator | 0.491 0.031 DBMET00884 | DBMET00884 | |
| 0.003 | 0.617 | 0.029 | 1,3-Beta-glucan synthase inhibitor | 0.029 0.017 DBMET00884 | DBMET00884 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |